Logo image of HZN

Horizon Global Corporation (HZN) Stock Fundamental Analysis

NYSE:HZN - New York Stock Exchange, Inc. - US44052W1045 - Common Stock - Currency: USD

1.76  0 (0%)

After market: 1.7501 -0.01 (-0.56%)

Fundamental Rating

0

HZN gets a fundamental rating of 0 out of 10. The analysis compared the fundamentals against 83 industry peers in the Automobile Components industry. HZN has a bad profitability rating. Also its financial health evaluation is rather negative. HZN does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

HZN had negative earnings in the past year.
HZN had a negative operating cash flow in the past year.
HZN Yearly Net Income VS EBIT VS OCF VS FCFHZN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 0 50M -50M -100M -150M -200M

1.2 Ratios

The profitability ratios for HZN are negative, so there is not much use analyzing them.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
HZN Yearly ROA, ROE, ROICHZN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 0 200 400 600

1.3 Margins

In the last couple of years the Operating Margin of HZN has declined.
With a Gross Margin value of 10.89%, HZN is not doing good in the industry: 65.12% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of HZN has declined.
HZN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 10.89%
OM growth 3YN/A
OM growth 5Y-16.98%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.93%
GM growth 5Y-5.9%
HZN Yearly Profit, Operating, Gross MarginsHZN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 0 10 -10 20 -20

0

2. Health

2.1 Basic Checks

HZN does not have a ROIC to compare to the WACC, probably because it is not profitable.
HZN has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, HZN has a worse debt to assets ratio.
HZN Yearly Shares OutstandingHZN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 5M 10M 15M 20M 25M
HZN Yearly Total Debt VS Total AssetsHZN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 200M 400M 600M

2.2 Solvency

HZN has an Altman-Z score of 0.51. This is a bad value and indicates that HZN is not financially healthy and even has some risk of bankruptcy.
HZN's Altman-Z score of 0.51 is on the low side compared to the rest of the industry. HZN is outperformed by 74.42% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 0.51
ROIC/WACCN/A
WACC8.79%
HZN Yearly LT Debt VS Equity VS FCFHZN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 0 100M 200M 300M

2.3 Liquidity

A Current Ratio of 1.12 indicates that HZN should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.12, HZN is doing worse than 81.40% of the companies in the same industry.
HZN has a Quick Ratio of 1.12. This is a bad value and indicates that HZN is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of HZN (0.45) is worse than 88.37% of its industry peers.
Industry RankSector Rank
Current Ratio 1.12
Quick Ratio 0.45
HZN Yearly Current Assets VS Current LiabilitesHZN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 100M 200M 300M

1

3. Growth

3.1 Past

HZN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -303.62%.
The Revenue for HZN has decreased by -14.92% in the past year. This is quite bad
HZN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.80% yearly.
EPS 1Y (TTM)-303.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-922.22%
Revenue 1Y (TTM)-14.92%
Revenue growth 3Y3.08%
Revenue growth 5Y3.8%
Sales Q2Q%-24.2%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
HZN Yearly Revenue VS EstimatesHZN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 200M 400M 600M 800M
HZN Yearly EPS VS EstimatesHZN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 0 -1 -2

0

4. Valuation

4.1 Price/Earnings Ratio

HZN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
HZN Price Earnings VS Forward Price EarningsHZN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
HZN Per share dataHZN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 15 20

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for HZN!.
Industry RankSector Rank
Dividend Yield N/A

Horizon Global Corporation

NYSE:HZN (2/7/2023, 8:04:00 PM)

After market: 1.7501 -0.01 (-0.56%)

1.76

0 (0%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)N/A N/A
Earnings (Next)03-08 2023-03-08/amc
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners83.22%
Ins Owner Change0%
Market Cap48.81M
Analysts42.5
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.07
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-3.56
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-2.41
FCFYN/A
OCF(TTM)-1.77
OCFYN/A
SpS24.35
BVpS-3.91
TBVpS-5.4
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 10.89%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5Y-16.98%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.93%
GM growth 5Y-5.9%
F-Score1
Asset Turnover1.65
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 91.92%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.12
Quick Ratio 0.45
Altman-Z 0.51
F-Score1
WACC8.79%
ROIC/WACCN/A
Cap/Depr(3y)65.3%
Cap/Depr(5y)71.66%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-303.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-922.22%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-14.92%
Revenue growth 3Y3.08%
Revenue growth 5Y3.8%
Sales Q2Q%-24.2%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-310.1%
EBIT growth 3YN/A
EBIT growth 5Y-13.83%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-673.16%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-333.6%
OCF growth 3YN/A
OCF growth 5YN/A